Showing all 8 results

Benlysta (belimumab)

£349.50£2,962.70
Benlysta (belimumab) is a medication used with other medicines to treat adults and children aged 5 years and above with systemic lupus erythematosus (SLE) and adults with active lupus nephritis (LN).

Dupixent (dupilumab)

£1,179.60£3,216.15
Dupixent (dupilumab) is a prescription medicine used to treat uncontrolled moderate-to-severe atopic dermatitis, moderate-to-severe asthma and chronic rhinosinusitis with nasal polyposis.

Gamifant (emapalumab-lzsg)

£9,558.80£18,736.25
Gamifant (emapalumab-lzsg) is a prescription medicine used to treat patients with primary haemophagocytic lymphohistiocytosis (HLH).

Lupkynis (voclosporin)

£13,683.30£13,983.30
Lupkynis (voclosporin) is a medication used with other medicines to treat adults with active lupus nephritis (LN).

Rezurock (belumosudil)

£15,157.42
Rezurock (belumosudil) is a medication used to treat chronic graft-versus-host disease (cGVHD).

Saphnelo (anifrolumab)

£1,000.00
Saphnelo (anifrolumab) is a medication used with other medicines to treat patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy.

Tarpeyo (budesonide)

£13,607.00
Tarpeyo (budesonide) is a medication used to reduce proteinuria in adults with a kidney disease called primary immunoglobulin A nephropathy (IgAN).

Velsipity (etrasimod)

£5,876.36
Velsipity (etrasimod) is a prescription medicine for the treatment of adult patients with moderately to severely active ulcerative colitis. Velsipity (etrasimod) is approved by the FDA in the USA.